Because cardiovascular disease is the leading cause of death in the United States, advances in its early detection and management are critical. New technology that allows physicians to assess cardiovascular disease risk before symptoms become apparent has the power to save lives and greatly reduce healthcare costs.

Test results, in printed and graphical form, can be referenced within minutes after completion of this FDA-cleared test. This test can be done easily, non-invasively, and at no specific medical risk to patients, greatly assisting physicians in the assessment of cardiovascular disease. 
 

Initial screening for vascular disease usually involves the use of an upper-arm blood pressure cuff device, which has been employed since the 1890's. This method can provide some information, yet it is limited in terms of assessing blood vessel health. 

Cardiovascular specialists spend considerable effort on evaluating heart function, including electrocardiograms (ECGs), echocardiograms and stress tests, but they are limited in their ability to assess the functional and structural abnormality of the arteries prior to the late phase of arterial obstruction. Beyond the limitations of the data provided, cost and time are often critical factors in consideration of these tests.

The CVProfilor^® measures a blood pressure waveform produced by the beating heart. Data captured by the CVProfilor^® during a patient test is quickly analyzed and reported to provide a clear, concise evaluation tool for physicians. 

The data provided by the CVProfilor^® System include:

• A graph of the blood pressure waveform, body mass index, systolic blood pressure, diastolic blood pressure, mean arterial blood pressure, pulse pressure, pulse rate; and
     

• Large artery elasticity and small artery elasticity.

Your office already has everything you need to begin using the CVProfilor^® today, and your patients' comfort and ease during the test is assured. 

To begin the test, the appropriate patient-specific data is collected through a series of inquiry screens. As your patient reclines comfortably, a blood pressure cuff is placed on the left upper arm and an Arterial PulseWave™ Sensor is placed on the right wrist overlying the radial artery. The instrument's monitor displays the waveform as it is sensed. Once data is collected and analyzed, you simply print the CVProfile™ Report.

The CVProfilor^® is a portable and easy-to-use complete system that requires no additional accessories or disposable components.

Contact our corporate office

Hypertension Diagnostics, Inc., headquartered in Eagan, Minnesota, was founded in July 1988 to develop a proprietary blood pressure waveform analysis methodology into a non-invasive means for measuring the elasticity of large and small arteries. 

HDI has developed this proprietary analysis technology which has been incorporated into the design of several products produced and manufactured at the Eagan, Minnesota location. The Company is also registered to market the CVProfilor^® MD-3000 System, for use by physicians and other health care professionals outside the U.S. 

Two CVProfilor^® instruments are designed for clinical use:

The CVProfilor^® DO-2020 CardioVascular Profiling System:
designed for use by U.S. physicians.

The CVProfilor^® MD-3000 CardioVascular Profiling System: 
designed for use by physicians outside the U.S. 

The HDI/PulseWave™ CR-2000 Research CardioVascular Profiling System also available.

Events, press releases and articles regarding HDI's technology.  MORE